PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Pramipexole - Parkinson's disease (neuroprotective therapy)
PAD Profile : Pramipexole - Parkinson's disease (neuroprotective therapy)
Keywords :
dopamine agonists, non-ergot-derived dopamine receptor agonists, PD
Brand Names Include :
Mirapexin, Oprymea, Pipexus
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
06 June 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Dopamine agonists are not recommended as a neuroprotective therapy except in the context of a clinical trial
Associated BNF Codes
04. Central Nervous System
04.09.01. Dopaminergic drugs used in parkinsonism